Automated text messages were as effective as direct phone calls in encouraging study participants to get the COVID-19 vaccine, according to a JAMA Network Open study yesterday from the Perelman School of Medicine at the University of Pennsylvania,.
A study of samples from two Brazilian rivers found a high incidence of colistin-resistant bacteria and MCR-1 producers, Brazilian and Portuguese researchers reported today in the Journal of Global Antimicrobial Resistance.
Following the reappearance of Ebola in the Democratic Republic of the Congo's (DRC's) Equateur province, the country today launched an rVSV-EBOV vaccine campaign, tapping an initial shipment of 200 doses, the World Health Organization (WHO) African regional office said today.
Three percent of 10,403 adults with COVID-19 pneumonia were diagnosed as having new-onset dementia after a median of 182 days, a significantly higher proportion than that observed with other types of pneumonia, finds a study yesterday in Open Forum Infectious Diseases.
An analysis conducted at hospitals in Michigan found that the more antibiotic stewardship strategies a hospital reported, the lower its overuse of antibiotics at discharge, researchers reported yesterday in Clinical Infectious Diseases.
Missed measles vaccinations and eroded surveillance during COVID-19 are setting up a perfect storm.
The US Centers for Disease Control and Prevention (CDC) yesterday sent a Health Alert Network notice to health providers warning that cases of measles and mumps have been detected in people recently evacuated from Afghanistan.
A review and meta-analysis of point-prevalence surveys conducted in Asia over the past two decades found concerning levels of resistance to first-line and last-resort antibiotics in foodborne pathogens isolated from aquatic animals, researchers reported late last week in Nature Communications.
A point-prevalence study (PPS) conducted in six Indonesian hospitals found a high rate of empirical use of broad spectrum antibiotics, researchers reported today in JAC-Antimicrobial Resistance.
Only 62.4% of 16-month-old US children received the MMR vaccine from June to August, down from 72.0% before the pandemic.
